Jason Bednar
Stock Analyst at Piper Sandler
(2.38)
# 2,485
Out of 4,896 analysts
173
Total ratings
43.48%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCR NovoCure | Reiterates: Overweight | $34 | $18.46 | +84.18% | 11 | Jun 27, 2025 | |
| COO The Cooper Companies | Reiterates: Overweight | $115 → $105 | $76.70 | +36.90% | 13 | May 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $110 | $95.13 | +15.63% | 12 | May 23, 2025 | |
| SOLV Solventum | Upgrades: Overweight | $78 → $87 | $75.88 | +14.65% | 6 | May 19, 2025 | |
| KRMD KORU Medical Systems | Maintains: Neutral | $4.5 → $3.5 | $3.73 | -6.17% | 7 | May 8, 2025 | |
| MASI Masimo | Reiterates: Overweight | $215 → $200 | $166.67 | +20.00% | 15 | May 7, 2025 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $260 → $185 | $177.50 | +4.23% | 9 | May 2, 2025 | |
| LUNG Pulmonx | Reiterates: Overweight | $10 → $9 | $2.65 | +239.62% | 11 | May 1, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $235 → $250 | $204.48 | +22.26% | 30 | May 1, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $20 → $16 | $16.62 | -3.73% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $74.53 | +3.32% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $17 | $20.72 | -17.95% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $13 | $11.89 | +9.34% | 2 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $1.59 | +183.91% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $230.72 | +14.86% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $2.19 | +173.97% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $3.15 | +122.22% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3.5 → $1 | $0.20 | +412.82% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $526.05 | -29.28% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $76.50 | +24.18% | 1 | Apr 19, 2023 |
NovoCure
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $18.46
Upside: +84.18%
The Cooper Companies
May 30, 2025
Reiterates: Overweight
Price Target: $115 → $105
Current: $76.70
Upside: +36.90%
Merit Medical Systems
May 23, 2025
Maintains: Overweight
Price Target: $106 → $110
Current: $95.13
Upside: +15.63%
Solventum
May 19, 2025
Upgrades: Overweight
Price Target: $78 → $87
Current: $75.88
Upside: +14.65%
KORU Medical Systems
May 8, 2025
Maintains: Neutral
Price Target: $4.5 → $3.5
Current: $3.73
Upside: -6.17%
Masimo
May 7, 2025
Reiterates: Overweight
Price Target: $215 → $200
Current: $166.67
Upside: +20.00%
Becton, Dickinson and Company
May 2, 2025
Downgrades: Neutral
Price Target: $260 → $185
Current: $177.50
Upside: +4.23%
Pulmonx
May 1, 2025
Reiterates: Overweight
Price Target: $10 → $9
Current: $2.65
Upside: +239.62%
Align Technology
May 1, 2025
Reiterates: Overweight
Price Target: $235 → $250
Current: $204.48
Upside: +22.26%
DENTSPLY SIRONA
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $16.62
Upside: -3.73%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $74.53
Upside: +3.32%
Apr 30, 2025
Maintains: Neutral
Price Target: $18 → $17
Current: $20.72
Upside: -17.95%
Apr 23, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $11.89
Upside: +9.34%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $1.59
Upside: +183.91%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $230.72
Upside: +14.86%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $2.19
Upside: +173.97%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $3.15
Upside: +122.22%
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.20
Upside: +412.82%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $526.05
Upside: -29.28%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $76.50
Upside: +24.18%